Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-20-000329
Filing Date
2020-02-14
Accepted
2020-02-14 16:05:00
Documents
1
Group Members
BIHUA CHENCORMORANT ASSET MANAGEMENT, LLCCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

Document Format Files

Seq Description Document Type Size
1 sc13ga.htm SC 13G/A 132042
  Complete submission text file 0000929638-20-000329.txt   133940
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

EIN.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Subject) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G/A | Act: 34 | File No.: 005-91006 | Film No.: 20619385
SIC: 2836 Biological Products, (No Diagnostic Substances)